4SC AG EBITDA
Cos'è EBITDA di 4SC AG?
EBITDA di 4SC AG è -€19.42
Qual è la definizione di EBITDA?
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA di aziende nel Health Care settore su XETRA rispetto a 4SC AG
Cosa fa 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Aziende con ebitda simili a 4SC AG
- BrainChip Ltd ha EBITDA di -$19.48
- Seabridge Gold ha EBITDA di -CAD$19.45
- The Flowr ha EBITDA di -CAD$19.45
- Century Legend () ha EBITDA di -HKD$19.44
- Rubicon Minerals ha EBITDA di -CAD$19.43
- Rubicon Minerals ha EBITDA di -CAD$19.43
- 4SC AG ha EBITDA di -€19.42
- Venus Concept ha EBITDA di -$19.40
- Navios Maritime ha EBITDA di -$19.40
- Aqua Bio Technology ASA ha EBITDA di -kr19.39
- Northfield Capital ha EBITDA di -CAD$19.36
- Dore Copper Mining ha EBITDA di -CAD$19.36
- Dore Copper Mining ha EBITDA di -CAD$19.36